Description
Lazolvan Max Capsules with Prolonged Release 75 mg. №10
Composition
Each capsule contains 75 mg of ambroxol hydrochloride as the active ingredient.
Mechanism of Action
Ambroxol, the active ingredient in Lazolvan Max capsules, acts as a mucolytic and expectorant agent. It enhances the production of respiratory tract fluid, facilitating the liquefaction and elimination of mucus through coughing.
Pharmacological Properties
Ambroxol hydrochloride in Lazolvan Max capsules exhibits mucolytic, secretolytic, and bronchosecretolytic properties. It aids in reducing the viscosity of mucus, promoting its clearance from the respiratory tract.
Indications for Use
Lazolvan Max capsules are specifically indicated for respiratory conditions characterized by excessive mucus production, such as chronic bronchitis, bronchiectasis, and asthma with bronchial secretion disorders.
Contraindications
Avoid using Lazolvan Max capsules if you have a known hypersensitivity to ambroxol or any other components of the product. Consult a healthcare professional for suitable alternatives in such cases.
Side Effects
Common side effects may include gastrointestinal disturbances, allergic reactions, and skin rashes. Discontinue use and seek medical attention if any adverse reactions occur.
Usage Instructions
The recommended dosage is one Lazolvan Max capsule (75 mg) per day, to be taken orally with a full glass of water. Adhere to the prescribed regimen for optimal therapeutic outcomes.
Advantages over Analogues
Lazolvan Max capsules with prolonged release offer the advantage of sustained drug action, ensuring a prolonged therapeutic effect with once-daily dosing. This feature enhances patient compliance and convenience compared to standard ambroxol formulations.
Suitable Patient Groups
Lazolvan Max capsules are suitable for use in adult patients, including the elderly, and adolescents over 12 years of age. Pediatric use should be as per the guidance of a healthcare provider.
Storage and Shelf Life
Store Lazolvan Max capsules in a cool, dry place away from direct sunlight. Ensure proper sealing of the packaging to protect from moisture. Check the expiration date on the package and do not use expired products.
Packaging Description
Lazolvan Max capsules are available in a pack size of 10 capsules, each containing 75 mg of ambroxol hydrochloride. The packaging is designed to maintain the integrity and quality of the product.
Clinical Evidence and Effectiveness
Clinical studies have demonstrated the efficacy of ambroxol in improving mucus clearance and reducing cough frequency in patients with respiratory disorders. The prolonged-release formulation of Lazolvan Max capsules ensures a consistent therapeutic effect over an extended period.
